Use of semaglutide and tirzepatide among people with multiple sclerosis
Published online on April 29, 2026
Abstract
Multiple Sclerosis Journal, Ahead of Print.
Background and Objectives:Little is known about glucagon-like peptide-1 receptor agonists (GLP1RAs) use in multiple sclerosis. We described the frequency and characteristics associated with use.Methods:A cross-sectional survey of NARCOMS Registry ...
Background and Objectives:Little is known about glucagon-like peptide-1 receptor agonists (GLP1RAs) use in multiple sclerosis. We described the frequency and characteristics associated with use.Methods:A cross-sectional survey of NARCOMS Registry ...